Key result
Ebstein anomaly is a congenital malformation of the tricuspid valve that can lead to cyanotic heart disease, as first described in 1866.
Key points are not available for this paper at this time.
Offers no new clinical guidance; leaves open need for contemporary outcome data in Ebstein anomaly.
Introduction In 1866, Dr Wilhelm Ebstein first described the clinical and anatomical features of the congenital anomaly of the tricuspid valve [1]. He described the case of a man who died of cyanotic heart disease secondary to a malformation of the tricuspid valve, which ultimately became known as Ebstein anomaly (EA).
No takes yet. Share an insight, caveat, or question.
Koutrolou-Sotiropoulou et al. (2015) studied this question. Ebstein anomaly is a congenital malformation of the tricuspid valve that can lead to cyanotic heart disease, as first described in 1866.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: